IL-6 and GM-CSF in tumor rejection model of renal cell cancer.
Wysocki
P J
PJ
Department of Cancer Immunology, University School of Medical Sciences, GreatPoland Cancer Center, Poznań, Poland.
Kowalczyk
D W
DW
Izycki
D
D
Grabarczyk
P
P
Kwias
Z
Z
Mackiewicz
A
A
D000818:Animals; D019496:Cancer Vaccines / Q000235:genetics / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D015316:Genetic Therapy; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics / Q000627:therapeutic use*; D015850:Interleukin-6 / Q000235:genetics / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D014407:Tumor Cells, Cultured
D019496:Cancer Vaccines; D015850:Interleukin-6; D016178:Granulocyte-Macrophage Colony-Stimulating Factor